Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Classificação em ações #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Preço da ação
$0.00023723
Última sincronização: 2024-08-26
Valor de mercado
$1.41K
Variação (1 dia)
111.67%
Variação (1 ano)
0.00%
País
FR
Negociar Pharnext S.A. (ALPHA)

Categoria

Histórico de dividendos de Pharnext S.A. (ALPHA)
Pharnext S.A. (símbolo da ação: ALPHA) realizou um total de 1 pagamentos de dividendos.
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: $0.20
Rendimento de dividendos (TTM): 0
Pagamentos de dividendos de Pharnext S.A. (ALPHA) de 2024 a 2026
Pagamentos anuais de dividendos
Ano Dividendo (ajustado para desdobramentos) Alterar
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Lista de todos os pagamentos de dividendos
Ano Dividendo Alterar
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Dividendos de empresas semelhantes ou concorrentes
Empresa Número de pagamentos de dividendos País
0.00%
US
0.00%
NL
0.00%
CH
29.00%
BE
0.00%
KR